Our Leadership

Michael Yurkowsky

Michael Yurkowsky

Chief Executive Officer

Michael Yurkowsky brings more than 25 years of experience in financial services to H-CYTE. In addition to serving as the Chief Executive Officer of H-CYTE, Yurkowsky currently serves as President and Chairman of Deverra Therapeutics, a clinical stage biotech developing allogeneic cell therapies.

Yurkowsky spent his early career working as a broker with several national broker-dealers and as a licensed investment banker. He went on to start and manage his own hedge fund, specializing in debt arbitrage. In 2012, he opened his own family office, YP Holdings LLC, which has invested in more than 50 private companies and participated in more than 100 public company financing transactions.

Throughout his career, Mr. Yurkowsky has served on multiple public and private boards and has been involved in several M&A transactions.

Tanya Rhodes, PhD

Tanya Rhodes, PhD

Chief Scientific Officer

Tanya Rhodes has more than 30 years of experience in global pharmaceutical development and innovation. She holds a Masters Degree with a major in Technology Management from the University of Miami and graduated with honors in Chemistry from Hull University, England.

Rhodes completed the full research for a PhD in Molecular Orbital Computational Stereochemistry.

Jeremy Daniel

Jeremy Daniel

Chief Financial Officer

Jeremy Daniel is highly experienced with financial, operations and strategic planning in an executive capacity. Daniel has broad-based expertise building and leading effective strategies for revenue production, operations management, team leadership and financial and accounting systems in the health care industry.

Since 2012, Daniel has served as the CFO of H-CYTE, where he co-leads vision, strategy and execution of all facets of financial, operations, strategic planning and organizational development. Daniel earned a bachelor’s degree in business administration from the University of Cincinnati and an MBA from Xavier University.